Companies by Sector - Pharmaceuticals and Biotechnology
| EPIC | Company | Index | Dividend Yield | Market Cap | Price Close | % Change |
|---|---|---|---|---|---|---|
| AZN | AstraZeneca | FTSE 100 | 1.80 | £208.75B | 13,600.00 | 1.04% |
| GSK | GSK | FTSE 100 | 3.25 | £75.48B | 1,876.50 | 1.32% |
| HLN | Haleon | FTSE 100 | 1.79 | £33.1B | 378.90 | 1.96% |
| HIK | Hikma Pharmaceuticals | FTSE 100 | 4.00 | £3.37B | 1,529.00 | 0.79% |
| GNS | Genus | FTSE 250 | 1.01 | £2.03B | 3,160.00 | 3.44% |
| HCM | Hutchmed China | AIM | £1.89B | 220.00 | 4.80% | |
| INDV | Indivior | FTSE 250 | £1.54B | 1,238.00 | -3.10% | |
| OXB | Oxford BioMedica | FTSE Small Cap | £1.03B | 831.00 | -2.24% | |
| AGY | Allergy Therapeutics | AIM | £730.83M | 11.90 | -2.50% | |
| PRTC | Puretech Health | FTSE Small Cap | £319.02M | 132.40 | 0.30% | |
| AVCT | Avacta Group | AIM | £225.26M | 51.50 | -7.00% | |
| ANCR | Animalcare Group | AIM | 1.84 | £195.4M | 283.00 | -2.60% |
| FARN | Faron Pharmaceuticals OY | AIM | £195.29M | 169.99 | 1.10% | |
| MXCT | Maxcyte Inc | AIM | £161.75M | 147.69 | -1.20% | |
| DXRX | Diaceutics | AIM | £144.35M | 170.00 | -0.50% | |
| SCLP | Scancell Holdings | AIM | £137.51M | 13.25 | -1.10% | |
| BMK | Benchmark Holdings | AIM | £135.69M | 22.05 | 1.50% | |
| STX | Shield Therapeutics | AIM | £114.79M | 10.75 | -7.90% | |
| ANP | Anpario | Main Market | 2.15 | £111.22M | 540.00 | -0.90% |
| BVXP | Bioventix | AIM | 8.11 | £96.66M | 1,850.00 | -2.20% |
| 4BB | 4basebio | AIM | £89M | 575.00 | -0.40% | |
| EAH | Eco Animal Health Group | AIM | £76.23M | 112.50 | -4.30% | |
| ANIC | Agronomics | AIM | £63.39M | 6.00 | -0.60% | |
| SBTX | SkinBioTherapeutics | AIM | £53.08M | 20.50 | -14.90% | |
| HVO | Hvivo | AIM | 3.33 | £40.82M | 6.00 | -5.10% |
| OBI | Ondine Biomedical Inc | AIM | £37.76M | 8.50 | 2.60% | |
| IMM | ImmuPharma | AIM | £31.97M | 6.36 | -3.00% | |
| AREC | Arecor Therapeutics | AIM | £30.77M | 81.50 | -1.30% | |
| POLB | Poolbeg Pharma | AIM | £30.68M | 4.40 | -2.10% | |
| ABDX | Abingdon Health | AIM | £26M | 6.00 | 2.60% | |
| SAR | Sareum Holdings | AIM | £24.16M | 17.50 | -5.60% | |
| EDEN | Eden Research | AIM | £20.8M | 3.90 | -2.40% | |
| OBD | Oxford BioDynamics | AIM | £11.8M | 0.27 | -4.00% | |
| GDR | Genedrive | AIM | £11.07M | 1.07 | -1.60% | |
| VRCI | Verici Dx | AIM | £10.97M | 0.70 | -4.80% | |
| IXI | Ixico | AIM | £10.43M | 11.25 | -1.50% | |
| CEL | Celadon Pharmaceuticals | AIM | £9.23M | 13.40 | % | |
| AGL | Angle | AIM | £7.72M | 2.40 | -0.70% | |
| FUM | Futura Medical | AIM | £7.67M | 1.32 | 14.60% | |
| OPTI | OptiBiotix Health | AIM | £7.49M | 7.03 | -3.30% | |
| PRM | Proteome Sciences | AIM | £6.31M | 1.84 | 8.00% | |
| TRX | Tissue Regenix Group | AIM | £5.16M | 7.25 | -1.50% | |
| VAL | ValiRx | AIM | £2.6M | 0.35 | -2.20% | |
| GUN | Gunsynd | AIM | £1.74M | 0.11 | 9.50% |